TABLE 2.
Serologic responses to sequential pneumococcal vaccinationa
| Time point | Serotype | |||||
|---|---|---|---|---|---|---|
| 2 | 3 | 6A | 9N | 11A | 14 | |
| Month 0 | 2.8 (1.8–6.7) |
0.3 (0.2–0.5) |
1.0 (0.5–1.8) |
1.5 (0.8–2.8) |
1.1 (0.6–1.8) |
4.8 (2.8–8.4) |
| Month 6 | 2.9 (1.9–7.5) |
0.6 (0.3–1.1) |
1.9 (1.0–3.0) |
1,6 (0.9–3.2) |
1.1 (0.7–1.9) |
13.4 (6.1–29.3) |
|
1.0
(0.8–1.2) |
2.7
(1.1–3.4) |
1.9
(1.1–2.8) |
1.0
(0.9–1.3) |
1.0
(0.9–1.1) |
2.8
(1.5–4.8) |
|
| Month 7 | 10.4 (5.3–17.8) |
0.9 (0.5–1.5) |
2.0 (1.0–3.1) |
4.3 (1.8–9.1) |
2.5 (1.1–4.9) |
15.5 (8.3–28.1) |
|
3.7
(1.7–6.4) |
2.9
(1.6–5.1) |
1.9
(1.2–3.2) |
2.9
(1.5–4.0) |
2.3
(1.3–3.4) |
3.2
(1.7–4.6) |
|
a
Geometric mean concentrations (IQR) (mg/L) are in roman type; geometric mean fold increases (IQR) are in italics; n = 57.